Preclinical studies of apogossypolone, a novel pan inhibitor of bcl-2 and mcl-1, synergistically potentiates cytotoxic effect of gemcitabine in pancreatic cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/19823097

Download in:

View as

General Info

PMID
19823097